Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver disease

Digestive and Liver Disease

Volumn 41, Issue 3, 2009, Pages 212-216

  Turato, C ^a   Ruvoletto, M G ^a   Biasiolo, A ^a   Quarta, S ^a   Tono, N ^b   Bernardinello, E ^a   Beneduce, L ^c   Fassina, G ^c   Cavalletto, L ^a   Chemello, L ^a   Merkel, C ^a   Gatta, A ^a   Pontisso, P ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c Xeptagen SpA   (Italy)

Author keywords

Fibrosis; Liver disease progression; SCCA polymorphism; Serpins

Indexed keywords

IMMUNOGLOBULIN M; SQUAMOUS CELL CARCINOMA ANTIGEN; SQUAMOUS CELL CARCINOMA ANTIGEN 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; WILD TYPE;

ADULT; ANTIGENS, NEOPLASM; CASE-CONTROL STUDIES; CHRONIC DISEASE; FEMALE; HUMANS; IMMUNOGLOBULIN M; LIVER DISEASES; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SERPINS;

EID: 60649086163     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2008.06.001     Document Type: Article

References (11)

1. Pontisso P., Calabrese F., Benvegnù L., Lise M., Belluco C., Ruvoletto M.G., et al. Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. Br J Cancer 90 (2004) 833-837
2. Giannelli G., Marinosci F., Sgarra C., Lupo L., Dentico P., and Antonaci S. Clinical role of tissue and serum levels of SCCA antigen in hepatocellular carcinoma. Int J Cancer 116 (2005) 579-583
3. Giannelli G., Fransvea E., Trerotoli P., Beaugrand M., Marinosci F., Lupo L., et al. Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients. Clin Chim Acta 383 (2007) 147-152
4. Beneduce L., Castaldi F., Marino M., Quarta S., Ruvoletto M.G., Benvegnù L., et al. Squamous cell carcinoma antigen-IgM complexes as novel biomarkers for hepatocellular carcinoma. Cancer 103 (2005) 2558-2565
5. Pontisso P., Quarta S., Caberlotto C., Beneduce L., Marino M., Bernardinello E., et al. Progressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma. Int J Cancer 119 (2006) 735-740
6. Huntington J.A., Read R.J., and Carrell R.W. Structure of a serpin-protease complex shows inhibition by deformation. Nature 407 (2000) 923-926
7. Pontisso P., Poon M.C., Tiollais P., and Brechot C. Detection of hepatitis B virus DNA in mononuclear blood cells. Br J Med 288 (1984) 1563-1566
8. Bataller R., North K.E., and Brenner D.A. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology 37 (2003) 493-503
9. Thorisson G.A., Smith A.V., Krishnan L., and Stein L.D. The International HapMap Project Web site. Genome Res 15 (2005) 1592-1593
10. Suminami Y., Nagashima S., Vujanovic N.L., Hirabayashi K., Kato H., and Whiteside T.L. Inhibition of apoptosis in human tumor cells by the tumor-associated serpin, SCC antigen-1. Br J Cancer 82 (2000) 981-989
11. Quarta S., Vidalino L., Ruvoletto M.G., Della Barbera M., Calabrese F., Valente M., et al. SCCA over-expression induces cell proliferation and down-regulation of the adhesion system. [abstract]. J Clin Virol 36 (2006) S193